Welcome to the Penn Center for AIDS Research
The Penn Center for AIDS Research (Penn CFAR) is one of 20 NIH-funded CFARs and includes HIV and AIDS investigators at the University of Pennsylvania, the Children's Hospital of Philadelphia (CHOP), and the Wistar Institute.
The Penn CFAR's mission is to support, encourage and facilitate research in all areas of HIV/AIDS on the Penn/CHOP/Wistar campus by (a) facilitating communication and interdisciplinary collaborations through workshops, working groups, strategic planning efforts, and a seminar series covering all topics in the field; (b) support innovative pilot research in HIV/AIDS through developmental pilot grant programs including nonhuman primate-based research; (c) mentoring and support of junior investigators; (d) services and training in support of HIV research through Shared Cores: Clinical, Viral/Molecular, Immunology, Biostatistics & Data Management; Behavioral and Social Sciences; International; Nonhuman Primate.
The Penn Center for AIDS Research is happy to announce a new funding mechanism available to junior faculty CFAR investigators (Instructor and Assistant Professor or equivalent) to obtain targeted data needed for resubmission of a scored grant, or other critical needs that will result in a stronger HIV research grant or related goals. This should be limited to key essential resources for which no other support is available. These grants will be implemented in FY2019, and will be subject to rigorous evaluation and review by the Developmental and Administrative Cores.
Please see the Microgrant Program page for more details.
The Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) is a consortium of more than 60 top HIV researchers from leading academic research institutions working with government, nonprofit organizations, and industry partners to test combinations of several novel immunotherapies under new preclinical research and clinical trials.
- First-of-its-Kind HIV ‘Nudge Unit’ in South Africa
February 5, 2020
Penn researchers at the Center for Health Incentives & Behavioral Economics (CHIBE) have established Indlela: Behavioural Insights for Better Health. Indlela is a Gates Foundation-funded initiative to build capacity to design and test nudges and other behavioural solutions to improve the effectiveness of health services and achieve better health outcomes in South Africa. The initial 3-year period of Indlela will focus specifically on building capacity to expand the use of behavioural economics within HIV prevention and treatment programs in South Africa. Full article HERE
- Testing the HIV Testers
November 8th, 2019
As part of the effort to end HIV in the U.S. by 2030, researchers at the School of Nursing are using mystery-shopper methodology to test the quality of HIV/STI testing for young men who have sex with men (YMSM). “This study’s systematic collection of YMSM’s experiences when seeking HIV testing and prevention services in three large metropolitan areas is an important step toward improving these services for youth,” José A. Bauermeister says. Full article HERE.
- Vaccine Progress
October 15th, 2019
A novel vaccine developed by researchers at the Perelman School of Medicine protected almost all animal subjects exposed to the herpes virus. The immunization led to “mostly sterilizing immunity” from the virus—the strongest type of immunity. This success paves the way for a round of human studies to test the efficacy and safety of the vaccine, says principal investigator Harvey Friedman. Full article HERE.
- Bauermeister Selected for Aspen Institute Health Innovators Fellowship.
July 15th, 2019
Twenty one senior health care leaders were chosen to join the Aspen Institute Health Innovators Fellowship’s fifth class and the program’s network of health care entrepreneurs and innovators from across the United States. These leaders – including Penn Nursing’s José Bauermeister, PhD, Presidential Professor, and Director of the Penn Program on Sexuality, Technology & Action Research (PSTAR) – will embark on a two-year Fellowship that will strengthen their leadership and challenge them to develop new approaches to improve the health and wellbeing of Americans. Full article HERE
- HIV Grand Rounds
12:00- 1:00 pm, Class of '62 Auditorium, John Morgan Building (unless otherwise posted)
- HIV / Pathogenesis CURE Journal Club
Every Other Thursday (starting again 9/20/18)
1:30- 3:00 pm, Room 501, Johnson Pavilion
© The Trustees of the University of Pennsylvania | Site best viewed in a supported browser. | Report Accessibility Issues and Get Help | Site Design: PMACS Web Team.